Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B2)
Clinical trial NCT07235033 · COMPLETED
Trial details
- NCT number
- NCT07235033
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-23
- Primary completion
- 2025-03-05
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.